erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
categories
.
.
.this website uses cookies. using this website means you are okay with this but you can find out more and learn how to manage your cookie choices
.
.